View in EDS HTML Full Text PDF Full Text

French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.

Saved in:
Bibliographic Details
Title: French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.
Authors: Ferment B; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France., Lambert J; Biostatistics Department, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France., Caillot D; Department of Hematology, Institut de Cancérologie de Bourgogne (ICB), Dijon, France.; Department of Hematology, Dijon University Hospital, Dijon, France., Lafon I; Department of Hematology, Institut de Cancérologie de Bourgogne (ICB), Dijon, France., Karlin L; Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Benite, France., Lazareth A; Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Benite, France., Touzeau C; Department of Hematology, Nantes University Hospital, Nantes, France., Leleu X; Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France., Moya N; Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France., Harel S; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France., Perrot A; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France., Bories P; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France., Vincent L; Department of Hematology, Montpellier University Hospital, Montpellier, France., Lamure S; Department of Hematology, Centre Léon Bérard, Lyon, France., Mohty M; Saint-Antoine Hospital, INSERM UMRs 938, Sorbonne University, Paris, France., Malard F; Saint-Antoine Hospital, INSERM UMRs 938, Sorbonne University, Paris, France., Manier S; Department of Hematology, Lille Regional and University Hospital, Lille, France., Yakoub-Agha I; Department of Hematology, Lille Regional and University Hospital, Lille, France., Schiano De Colella JM; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Brisou G; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Talbot A; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France., Decaux O; Department of Hematology, Rennes University Hospital, Pontchaillou Hospital, Rennes, France., Houot R; Department of Hematology, Rennes University Hospital, Pontchaillou Hospital, Rennes, France., Le Gouill S; Université Versailles Saint-Quentin, Versailles, France.; Department of Hematology, Institut Curie, Paris, France., Bigot N; Biostatistics Department, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France., Facon T; Department of Hematology, Lille Regional and University Hospital, Lille, France., Corre J; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France., Moreau P; Department of Hematology, Nantes University Hospital, Nantes, France., Arnulf B; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.
Corporate Authors: Intergroupe Francophone du Myélome
Source: British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 990-998. Date of Electronic Publication: 2024 May 15.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38747092
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ferment+B%22">Ferment B</searchLink>; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lambert+J%22">Lambert J</searchLink>; Biostatistics Department, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Caillot+D%22">Caillot D</searchLink>; Department of Hematology, Institut de Cancérologie de Bourgogne (ICB), Dijon, France.; Department of Hematology, Dijon University Hospital, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lafon+I%22">Lafon I</searchLink>; Department of Hematology, Institut de Cancérologie de Bourgogne (ICB), Dijon, France.<br /><searchLink fieldCode="AU" term="%22Karlin+L%22">Karlin L</searchLink>; Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Lazareth+A%22">Lazareth A</searchLink>; Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Touzeau+C%22">Touzeau C</searchLink>; Department of Hematology, Nantes University Hospital, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Moya+N%22">Moya N</searchLink>; Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Harel+S%22">Harel S</searchLink>; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Bories+P%22">Bories P</searchLink>; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Vincent+L%22">Vincent L</searchLink>; Department of Hematology, Montpellier University Hospital, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Lamure+S%22">Lamure S</searchLink>; Department of Hematology, Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Mohty+M%22">Mohty M</searchLink>; Saint-Antoine Hospital, INSERM UMRs 938, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Malard+F%22">Malard F</searchLink>; Saint-Antoine Hospital, INSERM UMRs 938, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Manier+S%22">Manier S</searchLink>; Department of Hematology, Lille Regional and University Hospital, Lille, France.<br /><searchLink fieldCode="AU" term="%22Yakoub-Agha+I%22">Yakoub-Agha I</searchLink>; Department of Hematology, Lille Regional and University Hospital, Lille, France.<br /><searchLink fieldCode="AU" term="%22Schiano+De+Colella+JM%22">Schiano De Colella JM</searchLink>; Department of Hematology, Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Brisou+G%22">Brisou G</searchLink>; Department of Hematology, Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Talbot+A%22">Talbot A</searchLink>; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Decaux+O%22">Decaux O</searchLink>; Department of Hematology, Rennes University Hospital, Pontchaillou Hospital, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; Department of Hematology, Rennes University Hospital, Pontchaillou Hospital, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Le+Gouill+S%22">Le Gouill S</searchLink>; Université Versailles Saint-Quentin, Versailles, France.; Department of Hematology, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bigot+N%22">Bigot N</searchLink>; Biostatistics Department, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; Department of Hematology, Lille Regional and University Hospital, Lille, France.<br /><searchLink fieldCode="AU" term="%22Corre+J%22">Corre J</searchLink>; Department of Hematology, IUCT Oncopole-Institut Universitaire du Cancer de Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; Department of Hematology, Nantes University Hospital, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Arnulf+B%22">Arnulf B</searchLink>; Department of Immuno-Hematology, Hôpital Saint Louis, APHP/Université Paris Cité, Paris, France.; Inserm U976 HIPI, Team 5: Lymphocyte Development and Lymphoid Disorders, Hôpital Saint Louis, Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Intergroupe+Francophone+du+Myélome%22">Intergroupe Francophone du Myélome</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 990-998. <i>Date of Electronic Publication: </i>2024 May 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38747092
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.19505
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 990
    Titles:
      – TitleFull: French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferment B
      – PersonEntity:
          Name:
            NameFull: Lambert J
      – PersonEntity:
          Name:
            NameFull: Caillot D
      – PersonEntity:
          Name:
            NameFull: Lafon I
      – PersonEntity:
          Name:
            NameFull: Karlin L
      – PersonEntity:
          Name:
            NameFull: Lazareth A
      – PersonEntity:
          Name:
            NameFull: Touzeau C
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Moya N
      – PersonEntity:
          Name:
            NameFull: Harel S
      – PersonEntity:
          Name:
            NameFull: Perrot A
      – PersonEntity:
          Name:
            NameFull: Bories P
      – PersonEntity:
          Name:
            NameFull: Vincent L
      – PersonEntity:
          Name:
            NameFull: Lamure S
      – PersonEntity:
          Name:
            NameFull: Mohty M
      – PersonEntity:
          Name:
            NameFull: Malard F
      – PersonEntity:
          Name:
            NameFull: Manier S
      – PersonEntity:
          Name:
            NameFull: Yakoub-Agha I
      – PersonEntity:
          Name:
            NameFull: Schiano De Colella JM
      – PersonEntity:
          Name:
            NameFull: Brisou G
      – PersonEntity:
          Name:
            NameFull: Talbot A
      – PersonEntity:
          Name:
            NameFull: Decaux O
      – PersonEntity:
          Name:
            NameFull: Houot R
      – PersonEntity:
          Name:
            NameFull: Le Gouill S
      – PersonEntity:
          Name:
            NameFull: Bigot N
      – PersonEntity:
          Name:
            NameFull: Facon T
      – PersonEntity:
          Name:
            NameFull: Corre J
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Arnulf B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 205
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1